Feasibility, Repeatability, and Correlation to Lung Function of Phase-Resolved Functional Lung (PREFUL) MRI-derived Pulmonary Artery Pulse Wave Velocity Measurements.

COPD lung pulmonary circulation pulmonary hypertension pulse wave velocity

Journal

Journal of magnetic resonance imaging : JMRI
ISSN: 1522-2586
Titre abrégé: J Magn Reson Imaging
Pays: United States
ID NLM: 9105850

Informations de publication

Date de publication:
09 Mar 2024
Historique:
revised: 22 02 2024
received: 21 12 2023
accepted: 22 02 2024
medline: 9 3 2024
pubmed: 9 3 2024
entrez: 9 3 2024
Statut: aheadofprint

Résumé

Pulse wave velocity (PWV) in the pulmonary arteries (PA) is a marker of vascular stiffening. Currently, only phase-contrast (PC) MRI-based options exist to measure PA-PWV. To test feasibility, repeatability, and correlation to clinical data of Phase-Resolved Functional Lung (PREFUL) MRI-based calculation of PA-PWV. Retrospective. 79 (26 female) healthy subjects (age range 19-78), 58 (24 female) patients with chronic obstructive pulmonary disease (COPD, age range 40-77), 60 (33 female) patients with suspected pulmonary hypertension (PH, age range 28-85). 2D spoiled gradient echo, 1.5T. PA-PWV was measured from PREFUL-derived cardiac cycles based on the determination of temporal and spatial distance between lung vasculature voxels using a simplified (sPWV) method and a more comprehensive (cPWV) method including more elaborate distance calculation. For 135 individuals, PC MRI-based PWV (PWV-QA) was measured. Intraclass-correlation-coefficient (ICC) and coefficient of variation (CoV) were used to test repeatability. Nonparametric tests were used to compare cohorts. Correlation of sPWV/cPWV, PWV-QA, forced expiratory volume in 1 sec (FEV sPWV and cPWV showed no significant differences between repeated measurements (P-range 0.10-0.92). CoV was generally lower than 15%. COPD and PH patients had significantly higher sPWV and cPWV than healthy subjects. Significant correlation was found between sPWV or cPWV and FEV PREFUL-derived PWV is feasible and repeatable. PWV is increased in COPD and PH patients and correlates to airway obstruction and hyperinflation. 3 TECHNICAL EFFICACY: Stage 2.

Sections du résumé

BACKGROUND BACKGROUND
Pulse wave velocity (PWV) in the pulmonary arteries (PA) is a marker of vascular stiffening. Currently, only phase-contrast (PC) MRI-based options exist to measure PA-PWV.
PURPOSE OBJECTIVE
To test feasibility, repeatability, and correlation to clinical data of Phase-Resolved Functional Lung (PREFUL) MRI-based calculation of PA-PWV.
STUDY TYPE METHODS
Retrospective.
SUBJECTS METHODS
79 (26 female) healthy subjects (age range 19-78), 58 (24 female) patients with chronic obstructive pulmonary disease (COPD, age range 40-77), 60 (33 female) patients with suspected pulmonary hypertension (PH, age range 28-85).
SEQUENCE UNASSIGNED
2D spoiled gradient echo, 1.5T.
ASSESSMENT RESULTS
PA-PWV was measured from PREFUL-derived cardiac cycles based on the determination of temporal and spatial distance between lung vasculature voxels using a simplified (sPWV) method and a more comprehensive (cPWV) method including more elaborate distance calculation. For 135 individuals, PC MRI-based PWV (PWV-QA) was measured.
STATISTICAL TESTS METHODS
Intraclass-correlation-coefficient (ICC) and coefficient of variation (CoV) were used to test repeatability. Nonparametric tests were used to compare cohorts. Correlation of sPWV/cPWV, PWV-QA, forced expiratory volume in 1 sec (FEV
RESULTS RESULTS
sPWV and cPWV showed no significant differences between repeated measurements (P-range 0.10-0.92). CoV was generally lower than 15%. COPD and PH patients had significantly higher sPWV and cPWV than healthy subjects. Significant correlation was found between sPWV or cPWV and FEV
DATA CONCLUSION CONCLUSIONS
PREFUL-derived PWV is feasible and repeatable. PWV is increased in COPD and PH patients and correlates to airway obstruction and hyperinflation.
LEVEL OF EVIDENCE METHODS
3 TECHNICAL EFFICACY: Stage 2.

Identifiants

pubmed: 38460124
doi: 10.1002/jmri.29337
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : German Center for Lung Research (DZL)

Informations de copyright

© 2024 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.

Références

Hunter KS, Lammers SR, Shandas R. Pulmonary vascular stiffness: Measurement, modeling, and implications in Normal and hypertensive pulmonary circulations. Compr Physiol 2011;1:1413.
Bramwell JC, Hill A. The Velocity of Pulse Wave in Man. Vol 19. London: Royal Society; 1922.
Sanz J, Kariisa M, Dellegrottaglie S, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2009;2:286-295.
Milan A, Zocaro G, Leone D, et al. Current assessment of pulse wave velocity: Comprehensive review of validation studies. J Hypertens 2019;37:1547-1557.
Bradlow WM, Gatehouse PD, Hughes RL, et al. Assessing normal pulse wave velocity in the proximal pulmonary arteries using transit time: A feasibility, repeatability, and observer reproducibility study by cardiovascular magnetic resonance. J Magn Reson Imaging 2007;25:974-981.
Voskrebenzev A, Gutberlet M, Klimeš F, et al. Feasibility of quantitative regional ventilation and perfusion mapping with phase-resolved functional lung (PREFUL) MRI in healthy volunteers and COPD, CTEPH, and CF patients. Magn Reson Med 2018;79:2306-2314.
Bauman G, Puderbach M, Deimling M, et al. Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI. Magn Reson Med 2009;62:656-664.
Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002;47:1202-1210.
Müller R, Klimeš F, Voskrebenzev A, et al. Influence of metronome-paced tachypnea on ventilation in COPD patients and healthy subjects. Proc Intl Soc Mag Reson Med 2023;1483.
Czerner CP, Winther HB, Zapf A, Wacker F, Vogel-Claussen J. Breath-hold and free-breathing 2D phase-contrast MRI for quantification of oxygen-induced changes of pulmonary circulation dynamics in healthy volunteers. J Magn Reson Imaging 2017;46:1698-1706.
Hohlfeld JM, Vogel-Claussen J, Biller H, et al. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): A double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med 2018;6:368-378.
Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
Lasch F, Karch A, Koch A, et al. Comparison of MRI and VQ-SPECT as a screening test for patients with suspected CTEPH: CHANGE-MRI study design and rationale. Front Cardiovasc Med 2020;7:511857.
Ronneberger O, Fischer P, Brox T. U-net: Convolutional networks for biomedical image segmentation. In: Navab N, Hornegger J, Wells W, Frangi A, editors. Medical Image Computing and Computer-Assisted Intervention-MICCAI 2015. MICCAI 2015. Lecture Notes in Computer Science, Vol 9351. Munich: Springer, Cham; 2015. p 234-241.
Wernz M, Voskrebenzev A, Müller R, et al. Feasibility of pulse wave velocity measurement in pulmonary arteries from phase-resolved functional lung MRI. Proc Intl Soc Mag Reson Med 2023;1785.
Isensee F, Jaeger PF, Kohl SAA, Petersen J, Maier-Hein KH. nnU-net: A self-configuring method for deep learning-based biomedical image segmentation. Nat Methods 2020;18:203-211.
Behrendt L, Voskrebenzev A, Klimeš F, et al. Validation of automated perfusion-weighted phase-resolved functional lung (PREFUL)-MRI in patients with pulmonary diseases. J Magn Reson Imaging 2020;52:103-114.
Zhang TY, Suen CY. A fast parallel algorithm for thinning digital patterns. Commun ACM 1984;27:236-239.
Peng HH, Chung HW, Yu HY, Tseng WYI. Estimation of pulse wave velocity in main pulmonary artery with phase contrast MRI: Preliminary investigation. J Magn Reson Imaging 2006;24:1303-1310.
Vulliémoz S, Stergiopulos N, Meuli R. Estimation of local aortic elastic properties with MRI. Magn Reson Med 2002;47:649-654.
Forouzan O, Warczytowa J, Wieben O, François CJ, Chesler NC. Non-invasive measurement using cardiovascular magnetic resonance of changes in pulmonary artery stiffness with exercise. J Cardiovasc Magn Reson 2015;17:1-10.
Ibrahim ESH, Shaffer JM, White RD. Assessment of pulmonary artery stiffness using velocity-encoding magnetic resonance imaging: Evaluation of techniques. Magn Reson Imaging 2011;29:966-974.
Lacharie M, Villa A, Milidonis X, Hasaneen H, Chiribiri A, Benedetti G. Role of pulmonary perfusion magnetic resonance imaging for the diagnosis of pulmonary hypertension: A review. World J Radiol. 2023;15:256-273.
Poon CY, Edwards JM, Evans CJ, et al. Assessment of pulmonary artery pulse wave velocity in children: An MRI pilot study. Magn Reson Imaging 2013;31:1690-1694.
Körperich H, Eckstein J, Atito M, et al. Assessment of pulmonary artery stiffness by multiparametric cardiac magnetic resonance-surrogate for right heart catheterization. Front Cardiovasc Med 2023;10:1200833.
Friesen RM, Schäfer M, Dunbar Ivy D, et al. Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension. Eur Heart J Cardiovasc Imaging 2019;20:209-217.
Weir-McCall JR, Kamalasanan A, Cassidy DB, Struthers AD, Lipworth BJ, Houston JG. Assessment of proximal pulmonary arterial stiffness using magnetic resonance imaging: Effects of technique, age and exercise. BMJ Open Respir Res 2016;3:e000149.
Kopeć G, Moertl D, Jankowski P, Tyrka A, Sobień B, Podolec P. Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension. Can J Cardiol 2013;29:683-690.
Horvat D, Zlibut A, Orzan RI, et al. Aging influences pulmonary artery flow and stiffness in healthy individuals: Non-invasive assessment using cardiac MRI. Clin Radiol 2021;76:161.e19-161.e28.
Gale NS, Albarrati AM, Munnery MM, et al. Aortic pulse wave velocity as a measure of cardiovascular risk in chronic obstructive pulmonary disease: Two-year follow-up data from the ARCADE study. Medicina (B Aires) 2019;55:89.
Cinarka H, Kayhan S, Gumus A, et al. Arterial stiffness measured via carotid femoral pulse wave velocity is associated with disease severity in COPD. Respir Care 2014;59:274-280.
Weir-Mccall JR, Struthers AD, Lipworth BJ, Houston JG. The role of pulmonary arterial stiffness in COPD. Respir Med 2015;109:1381-1390.
Liu CY, Parikh M, Bluemke DA, et al. Pulmonary artery stiffness in chronic obstructive pulmonary disease (COPD) and emphysema: The multi-ethnic study of atherosclerosis (MESA) COPD study. J Magn Reson Imaging 2018;47:262-271.
Guazzi M, Ghio S, Adir Y. Pulmonary hypertension in HFpEF and HFrEF: JACC review topic of the week. J Am Coll Cardiol 2020;76:1102-1111.
Okamoto M, Shipley MJ, Wilkinson IB, et al. Does poorer pulmonary function accelerate arterial stiffening? A cohort study with repeated measurements of carotid-femoral pulse wave velocity. Hypertension 2019;74:929-935.
Mueller-Graf F, Frenkel P, Albus CF, et al. Ventilation induces changes in pulse wave transit time in the pulmonary artery. Biomedicines 2023;11:182.
Vogel-Claussen J, Schönfeld CO, Kaireit TF, et al. Effect of indacaterol/glycopyrronium on pulmonary perfusion and ventilation in hyperinflated patients with chronic obstructive pulmonary disease (CLAIM) a double-blind, randomized, crossover trial. Am J Respir Crit Care Med 2019;199:1086-1096.
Voskrebenzev A, Kaireit TF, Klimeš F, et al. PREFUL MRI depicts dual bronchodilator changes in COPD: A retrospective analysis of a randomized controlled trial. Radiol Cardiothorac Imaging 2022;4:4.
Mueller-Graf F, Merz J, Bandorf T, et al. Correlation of pulse wave transit time with pulmonary artery pressure in a porcine model of pulmonary hypertension. Biomedicines 2021;9:1212.
Forouzan O, Dinges E, Runo JR, Keevil JG, Eickhoff JC, Francois C, Chesler NC. Exercise-Induced Changes in Pulmonary Artery Stiffness in Pulmonary Hypertension. Front Physiol. 2019;10:269.

Auteurs

Marius M Wernz (MM)

Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

Andreas Voskrebenzev (A)

Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

Robin A Müller (RA)

Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

Maximilian Zubke (M)

Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

Filip Klimeš (F)

Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

Julian Glandorf (J)

Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

Christoph Czerner (C)

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.

Frank Wacker (F)

Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

Karen M Olsson (KM)

Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.

Marius M Hoeper (MM)

Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.

Jens M Hohlfeld (JM)

Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.

Jens Vogel-Claussen (J)

Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

Classifications MeSH